¼¼°èÀÇ ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀå
Hypertrophic and Keloid Scar Treatment
»óǰÄÚµå : 1768116
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 376 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,160,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,480,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 168¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 96¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 9.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 168¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±¹¼Ò ¿µ¿ªÀº CAGR 9.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 73¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¹ÀÌÀú ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 25¾ï ´Þ·¯, Áß±¹Àº CAGR 14.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀåÀº 2024³â¿¡ 25¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 44¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 14.0%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 5.1%¿Í 8.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ºñÈļº ÈäÅÍ¿Í ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á°¡ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ºñÈļº ÈäÅÍ¿Í ÄÌ·ÎÀ̵å ÈäÅÍ´Â ÇǺΰ¡ »óó¿¡¼­ ȸº¹ÇÒ ¶§ ¹ß»ýÇÏ´Â °úµµÇÑ ÈäÅÍÀÇ ÀÏÁ¾À¸·Î, Á¾Á¾ ÇǺΰ¡ ºÎÇ®¾î ¿À¸£°í µÎ²¨¿öÁö¸ç ¶§·Î´Â ÅëÁõ°ú °¡·Á¿òÁõÀ» µ¿¹ÝÇÏ´Â ºÎÀ§°¡ ¹ß»ýÇϱ⵵ ÇÕ´Ï´Ù. ºñÈļº ÈäÅͰ¡ ¿ø·¡ »óóÀÇ °æ°è ³»¿¡ ¸Ó¹«¸£´Â ¹Ý¸é, ÄÌ·ÎÀ̵å´Â ±× °æ°è¸¦ ³Ñ¾î Á¡Â÷ÀûÀ¸·Î ¼ºÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÈäÅÍ´Â ´Ü¼øÈ÷ ¹Ì¿ëÀûÀÎ ¹®Á¦»Ó¸¸ ¾Æ´Ï¶ó ¿Ü°ü»óÀÇ ºÒÆíÇÔ, ¿òÁ÷ÀÓÀÇ Á¦ÇÑ, Á¤½Å°Ç°­¿¡µµ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ºñÈļº ÈäÅͳª ÄÌ·ÎÀ̵å ÈäÅÍÀÇ Ä¡·á¿¡´Â ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å ÁÖ»ç, ·¹ÀÌÀú Ä¡·á, ½Ç¸®ÄÜ ½ÃÆ®, ¿Ü°úÀû ÀýÁ¦¼ú µîÀÌ ÀÖÀ¸¸ç, ÈäÅÍÀÇ Å©±â¸¦ ÁÙÀ̰í, Áú°¨À» °³¼±Çϸç, ÅëÁõ°ú °¡·Á¿òÁõ µîÀÇ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

±â¼ú Çõ½ÅÀº ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á¸¦ ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

ÃÖ±Ù ÈäÅÍ Ä¡·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ºñÈļº ÈäÅÍ¿Í ÄÌ·ÎÀ̵å ÈäÅÍ È¯ÀÚÀÇ Ä¡·á ¼ºÀûÀÌ ´«¿¡ ¶ç°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ·¹ÀÌÀú Ä¡·á, ƯÈ÷ ºÐ¼ö CO2 ·¹ÀÌÀú¿Í ÆÞ½ºÇü »ö¼Ò ·¹ÀÌÀú´Â ÈäÅÍÀÇ µÎ²²¸¦ ÁÙÀ̰í, Áú°¨À» °³¼±Çϸç, ¹ßÀûÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ÇöÀç ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ·¹ÀÌÀú´Â ÈäÅÍ Á¶Á÷ÀÇ Äݶó°Õ À籸¼ºÀ» ÀÚ±ØÇÏ¿© È¿°ú¸¦ ¹ßÈÖÇÕ´Ï´Ù. ÈäÅÍ Á¶Á÷À» µ¿°á½ÃŰ´Â ³Ãµ¿¿ä¹ýµµ ÄÌ·ÎÀ̵åÀÇ È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¸Åø¸®´®Åå½Å°ú °°Àº ÁÖ»ç Ä¡·áµµ ÈäÅÍ Çü¼ºÀ» ¾ïÁ¦ÇÏ´Â ´É·Â¿¡ ´ëÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ·¹ÀÌÀú³ª ½Ç¸®ÄÜ ½ÃÆ®¿Í °°Àº ¿©·¯ Ä¡·á¹ýÀ» ÇÔ²² »ç¿ëÇÏ´Â º¹ÇÕ Ä¡·á´Â º¸´Ù Á¾ÇÕÀûÀÎ ÇØ°áÃ¥À» Á¦°øÇÏ¿© Àüü ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀåÀ» ¾î¶»°Ô Á¤ÀÇÇմϱî?

Ä¡·á À¯Çü¿¡´Â ±¹¼Ò Ä¡·á, ·¹ÀÌÀú Ä¡·á, ÁÖ»ç Ä¡·á, ¿Ü°úÀû ½Ã¼ú µîÀÌ ÀÖÀ¸¸ç, ·¹ÀÌÀú Ä¡·á¿Í ÁÖ»ç Ä¡·á´Â ±× È¿°ú¿Í ÃÖ¼Òħ½À¼ºÀ¸·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡´Â ÇǺΰú Ŭ¸®´Ð, º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅͰ¡ Æ÷ÇԵǸç, ÇǺΰú Ŭ¸®´ÐÀº ÈäÅÍ °ü¸® ¹× Ä¡·á¿¡ ƯȭµÇ¾î ÀÖ¾î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì, À¯·´ µî ÷´Ü ÇǺΰú Ä¡·á°¡ ³Î¸® º¸±ÞµÈ Áö¿ª¿¡¼­ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ¹Ì¿ë ¹× Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­µµ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÈäÅÍ °ü¸® ±â¼úÀÇ ¹ßÀü, ºñÈļº ÈäÅÍ ¹× ÄÌ·ÎÀ̵å ÈäÅÍÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÈäÅÍÀÇ ¹Ì¿ë ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÈäÅÍÀÇ ¸ð¾ç°ú Áõ»óÀ» °³¼±Çϱâ À§ÇØ Àü¹®ÀûÀÎ °³ÀÔÀ» ¿øÇϴ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÷´Ü ·¹ÀÌÀú Ä¡·á ¹× º¹ÇÕ Ä¡·á¿Í °°Àº ±â¼ú Çõ½ÅÀº º¸´Ù È¿°úÀûÀÌ°í ´ú ħ½ÀÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ¼ö¼ú ¹× ¿Ü»ó ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÈäÅÍ °ü¸® Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(±¹¼Ò, ·¹ÀÌÀú, ÁÖ»ç, ±âŸ Á¦Ç° À¯Çü), ÈäÅÍ À¯Çü(ÄÌ·ÎÀ̵å, ºñÈļº), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, Ŭ¸®´Ð, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hypertrophic and Keloid Scar Treatment Market to Reach US$16.8 Billion by 2030

The global market for Hypertrophic and Keloid Scar Treatment estimated at US$9.6 Billion in the year 2024, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$7.3 Billion by the end of the analysis period. Growth in the Laser segment is estimated at 10.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 14.0% CAGR

The Hypertrophic and Keloid Scar Treatment market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Hypertrophic and Keloid Scar Treatment Market - Key Trends and Drivers Summarized

Why Is the Treatment of Hypertrophic and Keloid Scars Significant?

Hypertrophic and keloid scars are types of excessive scarring that occur when the skin heals from an injury, often leading to raised, thickened, and sometimes painful or itchy areas on the skin. While hypertrophic scars remain within the boundary of the original wound, keloids extend beyond it, growing progressively. These scars are more than just cosmetic concerns; they can cause discomfort, restrict movement, and affect mental health due to their appearance. Treatments for hypertrophic and keloid scars include corticosteroid injections, laser therapy, silicone sheets, and surgical removal, with the goal of reducing scar size, improving texture, and relieving symptoms such as pain and itching.

How Are Technological Innovations Improving Hypertrophic and Keloid Scar Treatment?

Recent advancements in scar treatment technologies have significantly improved outcomes for patients with hypertrophic and keloid scars. Laser therapies, particularly fractional CO2 and pulsed dye lasers, are now widely used to reduce scar thickness, improve texture, and minimize redness. These lasers work by stimulating collagen remodeling in the scar tissue. Cryotherapy, which involves freezing the scar tissue, is also gaining traction as an effective treatment for keloids. Additionally, injectable treatments like botulinum toxin are being explored for their ability to inhibit scar formation. Combination therapies, which use multiple treatment modalities such as lasers and silicone sheets, are providing more comprehensive solutions and improving overall patient outcomes.

How Do Market Segments Define the Hypertrophic and Keloid Scar Treatment Market?

Treatment types include topical treatments, laser therapy, injectable treatments, and surgical procedures, with laser therapy and injectable treatments leading the market due to their effectiveness and minimally invasive nature. End-users include dermatology clinics, hospitals, and ambulatory surgical centers, with dermatology clinics holding the largest market share due to their specialization in scar management and treatment. Geographically, the market is growing in regions such as North America and Europe, where advanced dermatology treatments are widely available, but it is also expanding in emerging markets where access to cosmetic and therapeutic treatments is increasing.

What Factors Are Driving the Growth in the Hypertrophic and Keloid Scar Treatment Market?

The growth in the hypertrophic and keloid scar treatment market is driven by several factors, including the increasing demand for aesthetic procedures, technological advancements in scar management, and the rising prevalence of hypertrophic and keloid scars. As awareness of cosmetic and therapeutic treatments for scars increases, more patients are seeking professional interventions to improve the appearance and symptoms of their scars. Technological innovations, such as advanced laser therapies and combination treatments, are further boosting the market by providing more effective and less invasive solutions. Additionally, the rising incidence of surgical procedures and traumatic injuries, particularly in developing regions, is driving the demand for scar management treatments.

SCOPE OF STUDY:

The report analyzes the Hypertrophic and Keloid Scar Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Topical, Laser, Injectable, Other Product Types); Scar Type (Keloid, Hypertrophic); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â